SecBot SecBot
SC 13G ·Filed Oct 13, 2026

USPH

U S PHYSICAL THERAPY INC /NV
NEUTRAL
Impact 3/10
Horizonimmediate Processed14d 7h ago SEC0001580642-26-006855
Passive investor 5%+ stake
Actionable Insight • Neutral

Copeland Capital's 6.3% passive stake is a routine disclosure for a fund crossing the 5% threshold. No activist intent is signaled. Monitor future 13G amendments for any accumulation above this level or a potential conversion to 13D if the fund changes strategy.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+5d
USPH ▲ +1.85% at T+5d
NEUTRAL call +1.85% · α vs SPY +3.00% · entry $85.44 → $87.02
Next anchor: T+20d in 13d
Latest observation: T+8 -0.25% FF3 residual α
Entry = T+0 close
Oct 13, 2026
via day close
T+1d
-0.62%
call -0.62% · α +0.46%
$84.91
settled 14d ago
T+5d
+1.85%
call +1.85% · α +3.00%
$87.02
settled 8d ago
T+20d
Pending
in 13d
T+60d
Pending
in 2mo

Price Chart

Loading chart...

Executive Summary

Copeland Capital Management, LLC filed a Schedule 13G disclosing a 6.3% passive stake in U.S. Physical Therapy, Inc. as of September 30, 2026. This is a new initial filing by Copeland Capital, which previously filed as an amendment on August 4, 2026. The stake represents 940,528 shares held in the ordinary course of business with no intent to influence control.

Key Financial Metrics

Stake
6.3%
Investor
Copeland Capital Management, LLC

Key Facts

  • Copeland Capital Management, LLC disclosed a 6.3% beneficial ownership stake in USPH as of 09/30/2026
  • Total shares held: 940,528 (includes 612,654 shares with sole voting power, 150,697 shared voting power, and 0 sole dispositive power)
  • Filer certifies passive intent under Rule 13d-1(b) — no intent to influence control
  • This is an initial Schedule 13G filing by Copeland Capital (previously filed as SC 13G/A on 08/04/2026 and initial SC 13G on 05/08/2026)

Financial Impact

6.3% passive stake — no financial impact from the filing itself

Risk Factors

  • No material risks identified from this passive stake filing

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G Filing (Primary)0001580642-26-006855
Document: 0001580642-26-006855-index.html0001580642-26-006855
Document: 0001580642-26-006855.txt0001580642-26-006855
5 reports for USPH
Performance horizon
33% Hit rate @ T+5 1 of 3 directional calls Went positive at some point 1 of 3 best @ T+1▲ +4.56%Feb 26, 2026
Filters
Rows
Reports for USPH — sortable, filterable
TypeNow
Oct 13, 2026
14d ago
SC 13G
NEUTRAL ★ 3/10
$85.44 $87.02▲ +1.85%▲ +3.00%$87.34 (+2.22%)
Aug 10, 2026
11w ago
8-K
MIXED ★ 5/10
$81.67 $78.21▼ −4.24%▼ −3.83%$87.34 (+6.94%)
May 6, 2026
24w ago
8-K
BEARISH ★ 6/10
$59.00 $60.14▼ −1.93%▼ −0.43%$87.34 (−48.03%)
Apr 15, 2026
27w ago
8-K
BULLISH ★ 7/10
$78.18 $74.76▼ −4.37%▼ −5.36%$87.34 (+11.72%)
Feb 26, 2026
34w ago
8-K
BULLISH ★ 8/10
$78.87 $82.14▲ +4.15%▲ +5.27%$87.34 (+10.74%)
Showing 5 of 5

US Market Status

Market Closed — Opens Thu (10h 57m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 13, 2026